( 2 )柳氮磺胺吡啶( salicylazosulfapyridine , SASP ):逐日 250 - 500mg 开始,然后每周增加 500mg ,直至逐日 2.0 g,疗效不较着者...
基于40个网页-相关网页
( 2 )柳氮磺胺吡啶( salicylazosulfapyridine , SASP ):逐日 250 - 500mg 开始,然后每周增加 500mg ,直至逐日 2.0 g,疗效不较着者...
基于8个网页-相关网页
柳氮磺胺吡啶 SASP ; Salazosulfapyridine ; SSZ ; Sulfasalazine
水杨酸偶氮磺胺吡啶 SASP ; sulfasalazine ; salicylazosulfapyridine ; Salazosulfapyridine
柳氮磺胺吡啶片 Sulfasalazine Tablets ; sulfasalazine
和柳氮磺胺吡啶 sulphasalazine ; SULFASALAZINE ; SZ
及柳氮磺胺吡啶 sulphasalazine ; SSZ
近年用柳氮磺胺吡啶 salicylazosulfapyridine ; SASP
的二线有柳氮磺胺吡啶 sulfasalaztine ; SSZ
水杨酸柳氮磺胺吡啶 salicylazosulfapyridine
对比柳氮磺胺吡啶 SASP ; salicylazosul-fapyridine
柳氮磺胺吡啶具有消炎和抗菌的性质,主要用于治疗溃疡性结肠炎和类风湿关节炎。
Sulfasalazine possesses both antiinflammatory and antibacterial properties and was mainly used to treat inflammatory bowel disease and rheumatoid arthritis.
目的探讨在常规应用非甾体抗炎药的基础上应用柳氮磺胺吡啶,对强直性脊柱炎的治疗价值。
Objective to discuss the application of azulfidine to ankylosing spondylitis on the basis of non-steroids as anti-inflammatory agents.
方法:165例溃疡性结肠炎患者随机分为治疗组和对照组,分别给予复方甘草酸苷和柳氮磺胺吡啶治疗,比较两组的临床疗效。
METHODS: 165cases of ulcerative colitis were divided into two groups: trial group (compound glycyrrhizin) and control group (sulfasalazine). The clinical effects were compared between two groups.
应用推荐